Good MorningThe equities markets got a boost on Friday after a stronger than expected non-farm payrolls report. The headline figure of 4.8 million was far above analysts’ estimates and has added fuel to the market’s melt-up. The down shot is that news related to the COVID-19 pandemic helped cap gains. Word of new record levels of cases in the U.S. has the markets worried about another round of economic interruption and the impact on earrings.
Despite the worry, Friday’s action was bullish as it set a new high and closed above the previous day’s action. The candle, a small doji, is a sign of indecision but one that will likely lead to higher prices over the next few weeks. With the reopening underway, economic data is going to be strong and that will drive bullish sentiment as the 2nd quarter earnings cycle gets underway.
Featured: The Marijuana Gold Rush Is Here... (Profits Run) 
|
Markets | | |
Vaccines are big business. No matter what else you could say about them—and you could say plenty, starting with “they're one of the greatest things modern civilization has to offer” and ending with “they're eventually going to kill us all”—it is thoroughly unden... Read the Full Story |
|
|
Markets | | |
New York-based Drive Shack (NYSE:DS) owns and operates innovative golf entertainment venues in the U.S. Its "social driving ranges", which are popular with the millennial and Generation Z crowd, put golf-related challenges at the center of a good excuse for people to get together and eat, drink, a... Read the Full Story |
|
Markets | | |
So...how do you feel about risk? There are investors out there who can't get enough of the stuff, and invest as Richard Branson lived for a good chunk of the last couple decades. There are others, meanwhile, who'd keep it at the barest minimum possible. For investors who crave risk, Tesla (NASDAQ:... Read the Full Story |
|
Markets | | | Pool Corporation (NASDAQ: POOL) stock increased by more than 2% yesterday; shares are now less than 1% away from breaking out to fresh all-time highs.
POOL distributes swimming pool maintenance products, equipment, and building materials through its sales centers. Some of the company’s produc... Read the Full Story |
|
Markets | | |
The big question heading into FedEx's (NYSE:FDX) fourth-quarter report was whether a pandemic-driven online shopping spree would outweigh lower business shipping volumes. The answer is a resounding yes.
The delivery and logistics giant announced a 2% decline in revenue to $17.4 billion but adjust... Read the Full Story |
|
From Our PartnersAmerica's $51 trillion recovery will be of unheard magnitude.
Only it's not from a single thing the government is doing. Or even from big corporations.
Instead, it's due to one tiny pioneering American company.
You won't believe what this made-in-America device does.
It's poised to create more millionaires than pot stocks, cryptos and Big Tech - combined! | | Click here for the full story. |
|
The Early Bird Stock Of The Day Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity and liver diseases. The company's lead product candidate, pemvidutide, a GLP-1/glucagon dual receptor agonist that is in Phase 2 trial for the treatment of obesity and metabolic dysfunction-associated steatohepatitis. It is also developing HepTcell, an immunotherapeutic product candidate, which is in Phase 2 clinical trial for patients chronically infected with the hepatitis B virus. The company was formerly known as Vaxin Inc. and changed its name to Altimmune, Inc. in September 2015. Altimmune, Inc. was founded in 1997 is headquartered in Gaithersburg, Maryland. | | View Today's Stock Pick |
|
